About Sance
Sance is a company. The company has 130 employees as of January 29, 2025. Sance offers products and services including Cephalosporin Injections and Cephalosporin Tablets and Capsules.
- Employees 130 as on 29 Jan, 2025
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
- Legal Name Sance Laboratories Pvt. Ltd
- Jurisdiction Kottayam, Kerala, India
-
Annual Revenue
$6.48 M (USD)13.11as on Mar 31, 2024
-
Net Profit
$463 K (USD)21.31as on Mar 31, 2024
-
EBITDA
$947.73 K (USD)47.21as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
130
as on Jan 29, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sance
Sance offers a comprehensive portfolio of products and services, including Cephalosporin Injections and Cephalosporin Tablets and Capsules.
Dry powder for injections is produced as part of Cephalosporin antibiotic formulations
Tablets and capsules are manufactured in Cephalosporin formulations for various uses
Funding Insights of Sance
Detailed funding history for Sance
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sance
Investment portfolio details for Sance
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sance
Detailed financials for Sance
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sance Comparisons
Peer comparison for Sance
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sance
Detailed competitors of Sance
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sance
Complete news archive for Sance
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sance
As of Jan 29, 2025, the latest employee count at Sance is 130.
Annual revenue of Sance is $6.48M as on Mar 31, 2024.
Sance is recognized for its role in manufacturing Cephalosporin antibiotic formulations, with operations established in 2003 in Kerala, India. Various dosage forms, such as injections, tablets, capsules, dry syrups, and sachets, are produced and supplied to over 50 countries across four continents. Accreditations including WHO-GMP and ISO standards are maintained, while contract manufacturing services are provided for pharmaceutical companies. Quality practices are adhered to, ensuring safety and efficacy in production processes. (72 words).
Sance offers Cephalosporin Injections and Cephalosporin Tablets and Capsules.